摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,4-bis<3-(ethylamino)propyl>piperazine | 113830-94-7

中文名称
——
中文别名
——
英文名称
1,4-bis<3-(ethylamino)propyl>piperazine
英文别名
3,3'-piperazine-1,4-diylbis(N-ethylpropan-1-amine);1,4-bis(N-ethyl-3-aminopropyl)piperazine;1,4-bis[3-(ethylamino)propyl]piperazine;N-ethyl-3-[4-[3-(ethylamino)propyl]piperazin-1-yl]propan-1-amine
1,4-bis<3-(ethylamino)propyl>piperazine化学式
CAS
113830-94-7
化学式
C14H32N4
mdl
——
分子量
256.435
InChiKey
DBQLHVSPJXDCIF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    365.5±10.0 °C(Predicted)
  • 密度:
    0.914±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.3
  • 重原子数:
    18
  • 可旋转键数:
    10
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    30.5
  • 氢给体数:
    2
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1,4-bis<3-(ethylamino)propyl>piperazine盐酸 生成 N-ethyl-3-[4-[3-(ethylamino)propyl]piperazin-1-yl]propan-1-amine;tetrahydrochloride
    参考文献:
    名称:
    BERGERON, RAYMOND J.;NEIMS, ALLEN H.;MCMANIS, JAMES S.;HAWTHORNE, THOMAS +, J. MED. CHEM., 31,(1988) N 6, 1183-1190
    摘要:
    DOI:
  • 作为产物:
    描述:
    1,4-双(3-氨基丙基)哌嗪 在 lithium aluminium tetrahydride 、 三乙胺 作用下, 以 四氢呋喃二氯甲烷 为溶剂, 反应 34.0h, 生成 1,4-bis<3-(ethylamino)propyl>piperazine
    参考文献:
    名称:
    Synthetic polyamine analogs as antineoplastics
    摘要:
    In this paper, we report on the synthesis and biological activity of a number of N-alkylated spermine compounds. The dialkylspermines N1,N12-dimethylspermine (DMSPM-2), N1,N12-diethylspermine (DESPM-3), and N1,N12-dipropylspermine (DPSPM-4) are all shown to inhibit the growth of L1210 cells in culture with IC50 values of less than 1 microM at 96 h. Furthermore, DESPM-3 is shown to be similarly active against Daudi and HL-60 cells in culture. A structure-activity relationship is shown to exist between the position at which spermine is alkylated and its antiproliferative properties. The activity of 10 microM DESPM-3 against L1210 cells was shown to be cytostatic, with greater than 90% cell viability by trypan blue exclusion, even after a 144-h exposure. When L1210 cells were treated with 10 microM DESPM-3 over a 144-h period, their size and mitochondrial DNA content were gradually but substantially diminished. However, flow cytometric measurements of the nuclear DNA content of these treated cells at 96 h indicated only slightly reduced S and G2 populations and significant changes only after 144 h. A cloning assay performed on the cells after 96 h of exposure to this drug (10 microM) indicated that the cells were not growing. Finally, when male DBA/2 mice, inoculated with L1210 leukemia cells, were treated with DESPM-3, their life span was increased in excess of 200% relative to untreated controls. Moreover, many long-term survivors were apparently tumor free at the end of the experiment (60 days).
    DOI:
    10.1021/jm00401a019
点击查看最新优质反应信息

文献信息

  • Diamide compounds and compositions containing the same
    申请人:Kowa Co., Ltd.
    公开号:US06297283B1
    公开(公告)日:2001-10-02
    The present invention relates to compounds represented by the following general formula (1): wherein A is a phenyl, naphthyl, dihydronaphthyl, indenyl, pyridyl, indolyl, isoindolyl, quinolyl or isoquinolyl group which may be substituted; X is a lower alkylene group which may be substituted, or the like; Y is a single bond or an alkylene group; Z is a group of —CH═CH—, —C≡C—, —(CH═CH)2—, —C≡C—CH═CH— or —CH═CH—C≡C—, or the like; and R is a hydrogen atom, a lower alkyl group or the like, and medicines comprising such a compound. These compounds have an excellent inhibitory effect on the production of an IgE antibody and are hence useful as antiallergic agents and the like.
    本发明涉及以下一般式(1)所代表的化合物: 其中A是苯基、萘基、二氢萘基、茚基、吡啶基、吲哚基、异吲哚基、喹啉基或异喹啉基,可以被取代;X是可以被取代的较低烷基烯基,或类似物;Y是单键或烷基烯基;Z是—CH═CH—、—C≡C—、—(CH═CH)2—、—C≡C—CH═CH—或—CH═CH—C≡C—等基团;R是氢原子、较低烷基基团或类似物,以及包含这种化合物的药物。这些化合物对IgE抗体的产生具有出色的抑制作用,因此可用作抗过敏药物等。
  • Novel antibacterial agents
    申请人:Christensen G. Burton
    公开号:US20070134729A1
    公开(公告)日:2007-06-14
    This invention relates to novel multibinding compounds (agents) that are antibacterial agents. The multibinding compounds of the invention comprise from 2-10 ligands covalently connected by a linker or linkers, wherein each of said ligands in their monovalent (i.e., unlinked) state have the ability to bind to a an enzyme involved in cell wall biosynthesis and metabolism, a precursor used in the synthesis of the bacterial cell wall and/or the bacterial cell surface thereby interfere with the synthesis and/or metabolism of the cell wall. In particular the multibinding compounds of the invention comprise from 2-10 ligands covalently connected by a linker or linkers, wherein each of said ligands has a ligand domain capable of binding to penicillin binding proteins, a transpeptidase enzyme, a substrate of a transpeptidase enzyme, a beta-lactamase enzyme, pencillinase enzyme, cephalosporinase enzyme, a transglycoslase enzyme, or a transglycosylase enzyme substrate; Preferably, the ligands are selected from the beta lactam or glycopeptide class of antibacterial agents.
    本发明涉及一种新型多结合化合物(药剂),其为抗菌剂。该发明的多结合化合物由2-10个配体通过连接剂或连接剂共价连接而成,其中每个单价(即未连接的)配体具有与细胞壁生物合成和代谢中的酶、合成细菌细胞壁和/或细菌细胞表面的前体有结合能力,从而干扰细胞壁的合成和/或代谢。特别地,本发明的多结合化合物由2-10个配体通过连接剂或连接剂共价连接而成,其中每个配体具有能够结合青霉素结合蛋白、横向肽酶酶、横向肽酶酶底物、β-内酰胺酶、青霉素酶、头孢菌素酶、横向转移酶酶或横向转移酶酶底物的配体结构域。优选地,配体选自β-内酰胺类或糖肽类抗菌剂。
  • NOVEL DIAMIDE COMPOUNDS AND DRUGS CONTAINING THE SAME
    申请人:KOWA CO. LTD.
    公开号:EP0934924A1
    公开(公告)日:1999-08-11
    The present invention relates to compounds represented by the following general formula (1): wherein A is a phenyl, naphthyl, dihydronaphthyl, indenyl, pyridyl, indolyl, isoindolyl, quinolyl or isoquinolyl group which may be substituted; X is a lower alkylene group which may be substituted, or the like; Y is a single bond or an alkylene group; Z is a group of -CH=CH-, -C≡C-, -(CH=CH)2-, -C≡C-CH=CH- or -CH=CH-C≡C-, or the like; and R is a hydrogen atom, a lower alkyl group or the like, and medicines comprising such a compound. These compounds have an excellent inhibitory effect on the production of an IgE antibody and are hence useful as antiallergic agents and the like.
    本发明涉及由以下通式(1)代表的化合物: 其中 A 是可被取代的苯基、萘基、二氢萘基、茚基、吡啶基、吲哚基、异吲哚基、 喹啉基或异喹啉基;X 是可被取代的低级亚烷基或类似基团;Y是单键或亚烷基;Z是-CH=CH-、-C≡C-、-(CH=CH)2-、-C≡C-CH=CH-或-CH=CH-C≡C-或类似基团;R是氢原子、低级烷基或类似基团,以及包含此类化合物的药物。这些化合物对 IgE 抗体的产生有很好的抑制作用,因此可用作抗过敏剂等。
  • Thermoplastische Poly(urethan-harnstoffe) mit bioziden Eigenschaften und Verfahren zu ihrer Herstellung
    申请人:GT Elektrotechnische Produkte GmbH
    公开号:EP2524934A2
    公开(公告)日:2012-11-21
    Diese Erfindung betrifft thermoplastische Poly(urethan-harnstoffe) (TPU) mit inhärent bioziden Eigenschaften. Die Erfindung umfasst ein Verfahren zur Herstellung von thermoplastischen Poly(urethanharnstoffen) mit bioziden Eigenschaften durch Umsetzung einer A-Komponente mit einer B-Komponente in Gegenwart von Zusatzstoffen, wobei die A-Komponente die Teilkomponenten A1) eine oder mehrere langkettige Dihydroxylverbindungen wie Polyesterdiole, Polyetherdiole, Polytetrahydrofurane, Polycaprolactone, Polycarbonatdiole und/oder Poly-α,ω-dihydroxybutadiene, A2) ein oder mehrere kurzkettige Diole wie Butan-1,4-diol, Hexan-1,6-diol, Ethylenglykol, Diethylenglykol, A3) ein oder mehrere sekundäre Diamine, ggf. A4) ein oder mehrere Katalysatoren, und die B-Komponente die Teilkomponenten B1) ein oder mehrere Diisocyanate oder B2) Prepolymere auf der Basis von Diolen mit 0 bis 50 Gew.-% freien (monomeren) Diisocyanaten umfassen, das dadurch gekennzeichnet ist, dass die Umsetzung in Gegenwart einer weiteren Teilkomponente A5), enthaltend eine oder mehrere biozidwirksame Verbindungen mit mindestens einer-NH- oder-NH2-Funktion im Molekül, durchgeführt wird und gleichzeitig oder anschließend eine Weiterverarbeitung der Poly(urethan-harnstoffe) erfolgt.
    本发明涉及具有固有杀菌特性的热塑性聚氨酯(TPU)。 本发明包括一种通过在添加剂存在下使 A 组分与 B 组分反应制备具有杀菌性能的热塑性聚氨酯的工艺,其中 A 组分包括以下子组分 A1) 一种或多种长链二羟基化合物,如聚酯二元醇、聚醚二元醇、聚四氢呋喃、聚己 内酯、聚碳酸酯二元醇和/或聚α,ω-二羟基丁二烯、 A2) 一种或多种短链二元醇,如丁烷-1,4-二醇、己烷-1,6-二醇、乙二醇、二甘醇、 A3) 一种或多种仲二胺,可选 A4) 一种或多种催化剂,B 组份包括以下子组分 B1) 一种或多种二异氰酸酯或 B2) 基于二元醇的预聚物,其中游离(单体)二异氰酸酯的重量百分比为 0 至 50%、 其特征在于,该反应是在另一种部分组分 A5) 的存在下进行的,该部分组分 A5) 含有一种或多种生物杀灭活性化合物,其分子中至少含有一个 NH 或 NH2 功能,聚氨酯脲的进一步加工是同时或随后进行的。
  • BERGERON, RAYMOND J.;NEIMS, ALLEN H.;MCMANIS, JAMES S.;HAWTHORNE, THOMAS +, J. MED. CHEM., 31,(1988) N 6, 1183-1190
    作者:BERGERON, RAYMOND J.、NEIMS, ALLEN H.、MCMANIS, JAMES S.、HAWTHORNE, THOMAS +
    DOI:——
    日期:——
查看更多